Urine Output Response to Fluid and Diuretic Therapy in Cardiac ICU Patients Monitored With FIZE kUO®

Launched by FIZE MEDICAL LTD · Jun 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how well doctors can manage fluid therapy (the use of fluids to treat patients) in patients recovering from heart surgery, specifically those who may be at risk for a condition called Acute Kidney Injury (AKI). The researchers will use a device called the FIZE kUO® to continuously monitor urine output in patients in the cardiac intensive care unit (CTICU). By keeping a close eye on how much urine patients produce, the study aims to understand how this information can help doctors make better decisions about fluid management, ultimately improving patient recovery after surgery.

To be eligible for this study, participants must be adults aged 18 and older who are scheduled for heart surgery, such as coronary artery bypass grafting (CABG) or valve surgery, and are expected to stay in the CTICU afterward. They must also be able to give their consent to join the study. However, individuals who are pregnant, on dialysis before surgery, or participating in other studies about urine output or kidney injury will not be included. If you or a loved one participates, you can expect close monitoring and care focused on your recovery after heart surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults aged 18 years and older scheduled for CABG or valve surgery and expected postoperative admission to CTICU
• • 2. Ability to provide informed consent
• Exclusion Criteria:
• • 1. Pregnancy
• • 2. Preoperative dialysis (chronic or acute)
• • 3. Enrollment in other interventional trials assessing urine output or AKI